[go: up one dir, main page]

DK204586A - Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet - Google Patents

Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet Download PDF

Info

Publication number
DK204586A
DK204586A DK204586A DK204586A DK204586A DK 204586 A DK204586 A DK 204586A DK 204586 A DK204586 A DK 204586A DK 204586 A DK204586 A DK 204586A DK 204586 A DK204586 A DK 204586A
Authority
DK
Denmark
Prior art keywords
cells
hybrid cells
hybrid
hepatitis
virus
Prior art date
Application number
DK204586A
Other languages
English (en)
Other versions
DK204586D0 (da
Inventor
Nicole Chenciner
Jean-Francois Houssais
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Publication of DK204586D0 publication Critical patent/DK204586D0/da
Publication of DK204586A publication Critical patent/DK204586A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
DK204586A 1985-05-02 1986-05-02 Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet DK204586A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR858506706A FR2581393B2 (fr) 1985-05-02 1985-05-02 Cellules hybrides productrices d'un antigene caracteristique du virus de l'hepatite b obtenu a partir d'hepatocytes et de cellules etablies de singe, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production de l'antigene susdit

Publications (2)

Publication Number Publication Date
DK204586D0 DK204586D0 (da) 1986-05-02
DK204586A true DK204586A (da) 1986-11-03

Family

ID=9318906

Family Applications (1)

Application Number Title Priority Date Filing Date
DK204586A DK204586A (da) 1985-05-02 1986-05-02 Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet

Country Status (12)

Country Link
US (1) US5112748A (da)
EP (1) EP0200653B1 (da)
JP (1) JPS6229971A (da)
AT (1) ATE51026T1 (da)
CA (1) CA1277934C (da)
DE (1) DE3669529D1 (da)
DK (1) DK204586A (da)
ES (1) ES8703519A1 (da)
FR (1) FR2581393B2 (da)
GR (1) GR861142B (da)
PT (1) PT82505B (da)
WO (1) WO1993013203A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7766329B1 (en) 1992-10-02 2010-08-03 Sierra Design Group Wheel indicator and ticket dispenser apparatus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757169A1 (de) * 1977-12-22 1979-07-05 Hoechst Ag Verfahren zur gewinnung insulin produzierender tierischer zellen
FR2458584A1 (fr) * 1979-06-08 1981-01-02 Pasteur Institut Vecteurs pour le transfert et l'expression de materiel genetique dans une cellule eucaryote et procede pour la production d'une proteine determinee dans des cellules eucaryotes
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
JPS6045848B2 (ja) * 1980-07-31 1985-10-12 株式会社林原生物化学研究所 ヒト成長ホルモンの製造方法
FR2500847B1 (fr) * 1981-03-02 1985-09-13 Pasteur Institut Marqueurs genetiques selectifs pour cellules eucaryotes, procede de mise en oeuvre de tels marqueurs et application des cellules contenant un tel marqueur a la fabrication de proteines determinees apres leur transformation par un adn correspondant
EP0062574A3 (en) * 1981-03-31 1982-12-29 The Regents Of The University Of California Virus protein synthesis
DE3245665A1 (de) * 1982-05-04 1983-11-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung
JPS58201988A (ja) * 1982-05-04 1983-11-25 ベ−リンガ−・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 永久培養可能な動物及びヒトの細胞系を得る方法
US4608339A (en) * 1983-10-25 1986-08-26 Yoakum George H Protoplast fusion method for high-frequency DNA transfection in human cells
FR2555607B2 (fr) * 1983-11-30 1986-10-03 Pasteur Institut Culture de cellules eucaryotes productrices d'une proteine vaccinante, notamment d'antigene hbs
FR2565995B1 (fr) * 1984-03-07 1987-10-23 Centre Nat Rech Scient Cellules hybrides productrices d'un polypeptide determine et obtenu a partir de cellules primaires naturellement capables d'exprimer ce polypeptide ou un polypeptide equivalent, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production dudit polypeptide

Also Published As

Publication number Publication date
EP0200653A1 (fr) 1986-11-05
FR2581393B2 (fr) 1989-07-21
EP0200653B1 (fr) 1990-03-14
CA1277934C (fr) 1990-12-18
ES555123A0 (es) 1987-03-01
ATE51026T1 (de) 1990-03-15
FR2581393A2 (fr) 1986-11-07
DK204586D0 (da) 1986-05-02
US5112748A (en) 1992-05-12
JPS6229971A (ja) 1987-02-07
DE3669529D1 (de) 1990-04-19
GR861142B (en) 1986-08-11
PT82505B (pt) 1989-12-29
PT82505A (fr) 1986-06-01
ES8703519A1 (es) 1987-03-01
WO1993013203A1 (fr) 1993-07-08

Similar Documents

Publication Publication Date Title
DK577783A (da) Vektor for udtrykkelse af et dna-segment i gaer
NO964445L (no) DNA-sekvens, vektor, vertscelle og fremgangsmåte for transfeksjon av hematopoeseceller med eksogen DNA
CA2064705A1 (en) Methods for Culturing HCV in Eukaryotic Cells
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
DK0935660T3 (da) Infektiöse kloner af RNA-virusser og vacciner og deraf afledte diagnostiske assays
DE69637631D1 (de) Künstliche säuger chromosome
DK639689D0 (da) Indfoering af dna i celler
DK0506945T3 (da) Fremgangsmåde til genoverførsel under anvendelse af retrotransposoner
DK0500917T3 (da) Vacciner og fremgangsmåder baseret på rekombinante herpes simplex virusser.
BE880670A (fr) Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
EP0484374A4 (en) Rapid, versatile and simple system for expressing genes in eukaryotic cells
DK0904351T3 (da) Dyreceller og fremgangsmåder til replikationen af influenzavirus
ES8605039A1 (es) Procedimiento para preparar una vacuna que comprende un derivado truncado, libre de una membrana de un tipo fijado a una membrana que tiene determinantes antigenicos expuestos.
DK149589D0 (da) Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme
EP0019218A3 (en) Influenza virus vaccines, process for preparing them, process for propagating influenza viruses and cell culture inoculated with influenza virus
DK204586D0 (da) Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet
EA199900144A1 (ru) Способ индуцирования вирусной устойчивости в растении
FR2604183B1 (fr) Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
EP0469348A3 (en) Cdna sequence and detection of hepatits c virus
DK246482A (da) Hybridvektor fremgangsmaade til forbedring af amplifikation og ekspression af hybridvektorer ved anvendelse af mitochondialt dna
DK631387A (da) Virusvektor
DK176387A (da) Fremgangsmaade til frembringelse af et funktionelt polypeptid i en eukaryot vaertscelle ved anvendelse af en rekombinant dna udtrykkelsesvektor omfattende en bk virusforstaerker
DK326285A (da) Dna-sekvens, expressionsvektor og anvendelse heraf til expression afstrukturgener i bakterier ved dyrkning i teknisk maalestok
ID24649A (id) Replikon virus epstein-barr kompak
DK0429587T3 (da) Fremgangsmåde til fremstilling af et regulationsprotein af HIV-1 under anvendelse af den humane cellelinie TH4-7-5

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment